Covaxin effective against the Brazil variant: ICMR-NIV study – The Indian Express
In a new study, scientists at Indian Council of Medical Research-National Institute of Virology have found that Covaxin is effective against the Brazil variant (B.1.128.2).
This comes close on the heels of their recent study that had also suggested that Covaxin was effective against both the UK variant and Indian (double mutant) variant B.1.617.
Presently, India is using two Covid 19 vaccines, Covaxin by Bharat Biotech and Covishield by Serum Institute of India, to vaccinate people across the country.
There is evidence suggesting that the country’s indigenous Covid-19 jab Covaxin is proving to be effective against some variants.
Dr Anthony Fauci, who is US President Joe Biden’s chief adviser on the Covid pandemic, quoted the recent Phase 3 clinical trials of ...